Figure 4From: In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC)The second modification of SAHA ligand. This utilises triazole as additional group of SAHA, without substituting the amide group.Back to article page